Drug therapy for adults with attention-deficit hyperactivity disorder.
about
Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHDThe adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorderAmphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adultsAmfetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adultsPotential adverse effects of amphetamine treatment on brain and behavior: a reviewExposure to attention deficit hyperactivity disorder medications during pregnancyImmediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adultsAntidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic reviewDoes the difference between physically active and couch potato lie in the dopamine system?An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adultsPossible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorderPharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.Similar and Different? Subjective Effects of Methylphenidate and Cocaine in Opioid-Maintained Patients.Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD.Abnormal behaviors and microstructural changes in white matter of juvenile mice repeatedly exposed to amphetamine.Use of methylphenidate in patients with cancer.Prevalence and assessment of biochemical parameters of attention-deficit hyperactivity disorder children in Bangladesh.ADHD in adults: a review of the literature.Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder.Current issues around the pharmacotherapy of ADHD in children and adults.Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity.Self-reported ADHD and adjustment in college: cross-sectional and longitudinal findings.A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology.Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment.Differential contribution of storage pools to the extracellular amount of accumbal dopamine in high and low responders to novelty: effects of reserpine.Adjustment to college in students with ADHD.Clinical Effects of Lisdexamfetamine and Mixed Amphetamine Salts Immediate Release in Adult ADHD: Results of a Crossover Design Clinical Trial
P2860
Q22241803-896A81D5-E611-4697-9B01-2B75F57806F1Q22241830-1B7B6A16-035E-48C6-8B04-7B4518A16BEFQ24236404-DE92E23A-DE94-4713-AF71-A539CDC420DEQ24241930-EE6498A0-38B2-49C6-82E4-04A513932B54Q24657966-72D38E4D-2D4F-4020-A34C-8BBE4EB3E132Q24679615-884DFE0E-DCB8-44BD-81F8-84F09DA1EB98Q26471999-4EAFF240-6284-4A83-A6BB-7191CF916642Q28236140-C2AED1F9-88AD-4439-93C6-26F29761D727Q33719306-04AE7E32-6BFC-4D85-95CE-8CA87BB4813BQ34220004-06B4351E-7AB9-41F9-8FE1-1FAF290313FAQ34221423-278FD6F6-94A4-4A3C-8994-DACFFE6557F2Q34251275-D6DBAC75-B3EB-4F16-9F8A-6BF9FBB7E29FQ34675992-85DFBDD3-2203-4A9E-8B4B-129C7922D5A8Q36161293-700DEF2F-FD1A-494F-B7BF-CFF12D0D64F2Q36168824-FC0241A4-6124-4248-B3A3-2DB2C7F8BA36Q36383595-E6B9F1C3-1933-4BCA-A023-B9736849EC25Q37011677-42766BC4-397B-43AC-8F37-D942A01D33C3Q37038168-ED00CFC0-E088-4167-9EA2-387463FB3271Q37194205-74977F26-B4AF-4B6C-BD5C-CB3797870467Q37314533-CE69538C-FADD-4040-A38C-1A256B2467FDQ38663434-1C5EE35E-9693-43E4-B2D8-6BC981E73131Q39976410-A41FACCD-23A6-4BB8-BD6D-C04A399D1BD3Q46722153-F656F647-B3C4-43C2-9A47-5AA13D68316AQ48286283-C499A7A6-86E6-4588-8122-DE213A2114E8Q48348492-05C407C4-74CF-4929-9E13-836680FC4209Q48387696-47288031-F1B9-4A9E-97B1-54B341470DC5Q57399685-DFC27119-3DE2-4947-A6F5-1BF7616C460B
P2860
Drug therapy for adults with attention-deficit hyperactivity disorder.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Drug therapy for adults with attention-deficit hyperactivity disorder.
@ast
Drug therapy for adults with attention-deficit hyperactivity disorder.
@en
type
label
Drug therapy for adults with attention-deficit hyperactivity disorder.
@ast
Drug therapy for adults with attention-deficit hyperactivity disorder.
@en
prefLabel
Drug therapy for adults with attention-deficit hyperactivity disorder.
@ast
Drug therapy for adults with attention-deficit hyperactivity disorder.
@en
P1433
P1476
Drug therapy for adults with attention-deficit hyperactivity disorder.
@en
P2093
Timothy E Wilens
P304
P356
10.2165/00003495-200363220-00002
P577
2003-01-01T00:00:00Z
P6179
1051804597